Immunotherapy for Inhalant Allergy

Clinicians should offer or refer to a clinician who can offer immunotherapy for patients with allergic rhinitis with or without allergic asthma if their patients’ symptoms are inadequately controlled with medical therapy, allergen avoidance, or both, or have a preference for immunomodulation. (Recommendation)

Clinicians should educate patients who are immunotherapy candidates regarding the differences between SCIT and SLIT (aqueous and tablet) including risks, benefits, convenience, and costs. (Recommendation)